Evidence map›Paper›PMID 25469849›Full record

ArticleKidney international2015

RGS4 inhibits angiotensin II signaling and macrophage localization during renal reperfusion injury independent of vasospasm.

Paul Pang, Xiaohua Jin, Brandon M Proctor, Michelle Farley, Nilay Roy, Matthew S Chin, Ulrich H von Andrian, Elisabeth Vollmann, Mario Perro, Ryan J Hoffman and 6 more

Open access · greenAbstract read
In one paragraph

Article in Kidney international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Pre-clinical model of severe glutathione peroxidase-3 deficiency and chronic kidney disease results in coronary artery thrombosis and depressed left ventricular function.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2018
    Article
  9. Article
  10. RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives.BioEssays : news and reviews in molecular, cellular and developmental biology · 2016
    Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 1 country.

Paul PangRenal Division, Department of Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Harvard Institutes of Medicine, Boston, Massachusetts, USA.
Xiaohua JinWashington University in St Louis School of Medicine, St Louis, Missouri, USA.
Brandon M ProctorWashington University in St Louis School of Medicine, St Louis, Missouri, USA.
Michelle FarleyBeth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Nilay RoyPartners Healthcare, Boston, Massachusetts, USA.
Matthew S ChinUniversity of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Ulrich H von Andrian1] Harvard Medical School, Boston, Massachusetts, USA [2] Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, Harvard University, Cambridge, Massachusetts, USA.
Elisabeth VollmannHarvard Medical School, Boston, Massachusetts, USA.
Mario PerroHarvard Medical School, Boston, Massachusetts, USA.
Ryan J HoffmanWesleyan University, Middletown, Connecticut, USA.
Joseph ChungRenal Division, Department of Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Harvard Institutes of Medicine, Boston, Massachusetts, USA.
Nikita ChauhanRenal Division, Department of Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Harvard Institutes of Medicine, Boston, Massachusetts, USA.
Murti MistriRenal Division, Department of Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Harvard Institutes of Medicine, Boston, Massachusetts, USA.
Anthony J MuslinWashington University in St Louis School of Medicine, St Louis, Missouri, USA.
Joseph V BonventreRenal Division, Department of Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Harvard Institutes of Medicine, Boston, Massachusetts, USA.
Andrew M SiedleckiRenal Division, Department of Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Harvard Institutes of Medicine, Boston, Massachusetts, USA.
Harvard University · USWashington University in St. Louis · USBrigham and Women's Hospital · USBeth Israel Deaconess Medical Center · USMass General Brigham · USRagon Institute of MGH, MIT and Harvard · USUniversity of North Carolina at Chapel Hill · USWesleyan University · US

Funding

UAB-UCSD O'Brien Core Center for Acute Kidney Injury ResearchP30DK079337 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MEHTA, RAVINDRA L. · 2008 to 2022
$18.3M
Visualizing Effects of Costimulation on Antiviral ImmunityP01AI078897 · NIAID · HARVARD MEDICAL SCHOOL · PI SHARPE, ARLENE H. · 2008 to 2012
$12.1M
KIDNEY INJURY MOLECULE-1 IN EPITHELIAL REPAIRR01DK072381 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI BONVENTRE, JOSEPH VINCENT · 2005 to 2025
$8.6M
Mechanisms of Ischemic Kidney Injury and RepairR37DK039773 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BONVENTRE, JOSEPH VINCENT · 1993 to 2021
$5.2M
Washington University Center for Kidney Disease ResearchP30DK079333 · NIDDK · WASHINGTON UNIVERSITY · PI HAMMERMAN, MARC RANDALL · 2007 to 2011
$5.1M
T Cell Activation in Lymph NodesR01AI069259 · NIAID · IMMUNE DISEASE INSTITUTE, INC. · PI VON ANDRIAN, ULRICH H · 2006 to 2015
$4.5M
BIDMC 9.4T 20cm Biospec MRI SystemS10RR028792 · NCRR · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BURSTEIN, DEBORAH · 2009 to 2009
$2.4M
RGS PROTEIN FUNCTION IN CARDIAC PHYSIOLOGYR01HL061567 · NHLBI · WASHINGTON UNIVERSITY · PI MUSLIN, ANTHONY JUSTIN · 2000 to 2008
$2.3M
THE ROLE OF REGULATOR OF G-PROTEIN SIGNALING 4 IN ACUTE KIDNEY INJURYK08DK089002 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI SIEDLECKI, ANDREW MICHAEL · 2011 to 2015
$795k
NCRR NIH HHS S10 RR028792NHLBI NIH HHS R01 HL061567NIAID NIH HHS P01 AI078897NIAID NIH HHS P01AI078897NIAID NIH HHS R01 AI069259NIAID NIH HHS R01AI069259NIDDK NIH HHS K08 DK089002NIDDK NIH HHS K08DK089002NIDDK NIH HHS P30 DK079333NIDDK NIH HHS P30 DK 079337NIDDK NIH HHS P30 DK079337NIDDK NIH HHS R01 DK072381NIDDK NIH HHS R37 DK039773NIDDK NIH HHS R37DK039773
6 · The paper itself

Abstract

Vascular inflammation is a major contributor to the severity of acute kidney injury. In the context of vasospasm-independent reperfusion injury we studied the potential anti-inflammatory role of the Gα-related RGS protein, RGS4. Transgenic RGS4 mice were resistant to 25 min injury, although post-ischemic renal arteriolar diameter was equal to the wild type early after injury. A 10 min unilateral injury was performed to study reperfusion without vasospasm. Eighteen hours after injury, blood flow was decreased in the inner cortex of wild-type mice with preservation of tubular architecture. Angiotensin II levels in the kidneys of wild-type and transgenic mice were elevated in a sub-vasoconstrictive range 12 and 18 h after injury. Angiotensin II stimulated pre-glomerular vascular smooth muscle cells (VSMCs) to secrete the macrophage chemoattractant RANTES, a process decreased by angiotensin II R2 (AT2) inhibition. However, RANTES increased when RGS4 expression was suppressed implicating Gα protein activation in an AT2-RGS4-dependent pathway. RGS4 function, specific to VSMC, was tested in a conditional VSMC-specific RGS4 knockout showing high macrophage density by T2 MRI compared with transgenic and non-transgenic mice after the 10 min injury. Arteriolar diameter of this knockout was unchanged at successive time points after injury. Thus, RGS4 expression, specific to renal VSMC, inhibits angiotensin II-mediated cytokine signaling and macrophage recruitment during reperfusion, distinct from vasomotor regulation.

Indexed as

VasoconstrictionAngiotensin IIAngiotensin II Type 2 Receptor BlockersAnimalsAortaArteriolesCells, CulturedChemokine CCL5HumansKidney CortexMacrophagesMiceMice, KnockoutMuscle, Smooth, VascularMyocytes, Smooth MuscleReceptor, Angiotensin, Type 2Angiotensin IIAngiotensin II Type 2 Receptor BlockersChemokine CCL5Receptor, Angiotensin, Type 2RGS4 proteinRGS Proteins

Identifiers

PMID25469849
PMCPMC4382433
OpenAlexW2003201883

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.